Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2b topical brepocitinib cream in mild to moderate chronic plaque psoriasis
jRCT2080224892Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2019
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of brepocitinib in plaque psoriasis (9 arms), sponsored by Pfizer. Primary endpoint: Change from baseline in PASI total score at Week 12. Started Sep 2019; status: completed.
02
Drugs
brepocitinib
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on jRCT2080224892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224892.